Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2011-03-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.01708-10PMID 21402850PMCID PMC3101407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill

  2012cited by this paper
• A higher dose of vancomycin in continuous infusion is needed in critically ill patients.

  2011cited by this paper
• Comparison of dopamine and norepinephrine in the treatment of shock.

  2010cited by this paper
• Augmented Renal Clearance

  2010cited by this paper
• Use of vancomycin pharmacokinetic–pharmacodynamic properties in the treatment of MRSA infections

  2010cited by this paper
• Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

  2009influential reference
• Pharmacokinetic issues for antibiotics in the critically ill patient

  2009cited by this paper
• Risk Factors and Outcomes of Methicillin-resistant Staphylococcus Aureus Bacteraemia in Critically Ill Patients: A Case Control Study

  2009cited by this paper
• Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

  2009cited by this paper
• Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.

  2009cited by this paper
• Optimizing Vancomycin Dosing through Pharmacodynamic Assessment Targeting Area under the Concentration-Time Curve/Minimum Inhibitory Concentration

  2009cited by this paper
• Prospectively Validated Dosing Nomograms for Maximizing the Pharmacodynamics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients

  2009cited by this paper
• Appropriate pharmacokinetic index for outcome in Staphylococcus aureus pneumonia.

  2007cited by this paper
• Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients

  2007cited by this paper
• Methicillin-resistant Staphylococcus aureus pneumonia treatment: do not confuse pharmacokinetics and pharmacodynamics.

  2007cited by this paper
• Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.

  2006cited by this paper
• The pharmacokinetic and pharmacodynamic properties of vancomycin.

  2006cited by this paper
• Population pharmacokinetic parameters of vancomycin in critically ill patients

  2006cited by this paper
• Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*

  2006cited by this paper
• Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units

  2004cited by this paper
• Methicillin-resistant Staphylococcus aureus in the critically ill.

  2004cited by this paper
• Methicillin resistant Staphylococcus aureus in the critically ill.

  2004cited by this paper
• Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections

  2004cited by this paper
• Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'

  2004cited by this paper
• Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.

  2004cited by this paper
• Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis*

  2003cited by this paper
• Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

  2002cited by this paper
• Continuous versus Intermittent Infusion of Vancomycin in Severe Staphylococcal Infections: Prospective Multicenter Randomized Study

  2001influential reference
• High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.

  2000cited by this paper
• A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models.

  1999cited by this paper
• Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

  1999cited by this paper
• Vancomycin dosing in morbidly obese patients

  1998cited by this paper
• Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

  1998cited by this paper
• Aminoglycoside Volume of Distribution and Illness Severity in Critically Ill Septic Patients

  1993cited by this paper
• APACHE II: A severity of disease classification system

  1985cited by this paper
• University of California, San Francisco

  1974cited by this paper

• Population Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Influence of Adsorptive Membranes.

  2026cites this paper
• Pharmacokinetics and Customized Dosing of Vancomycin in Adult Patients With Hematological Malignancies: Status, Challenges, and Opportunities

  2026cites this paper
• Predictive Performance of Bayesian Dosing Software for Vancomycin in Intensive Care Unit Patients

  2025cites this paper
• Generating and Modeling Virtual Patient Data from Published Population Pharmacokinetic Analyses: A Vancomycin Case Study

  2025influential citation
• Anti-Infective-Associated AKI: A Narrative Review of the Epidemiology, Mechanisms, Risk Factors, Biomarkers, Clinical Course, Monitoring, Prevention, and Therapeutic Strategies

  2025cites this paper
• [Intravenous vancomycin therapy of adults guided by pharmacokinetic-pharmacodynamic targets].

  2025cites this paper
• An optimal antibiotic selection framework for Sepsis patients using Artificial Intelligence

  2024cites this paper
• Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review

  2024cites this paper
• Population Pharmacokinetic of Vancomycin Administered by Continuous Infusion in Critically Ill Patients

  2024influential citation
• Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling

  2024cites this paper
• Development of a model to predict vancomycin serum concentration during continuous infusion of vancomycin in critically ill pediatric patients

  2024cites this paper
• Assay Interference Causing Persistently Elevated Vancomycin Levels Leading to Treatment Failure and Fatal Outcome

  2024cites this paper
• Protective effects of silymarin on preventing vancomycin nephrotoxicity in infectious patients: a randomized, double-blinded, placebo-controlled, pilot clinical trial

  2024cites this paper
• Systematic Evaluation of Osimertinib Population Pharmacokinetic Models in a Cohort of Dutch Adults with Non-Small Cell Lung Cancer

  2024cites this paper
• External Validation of Obese/Critically Ill Vancomycin Population Pharmacokinetic Models in Critically Ill Patients Who Are Obese

  2023cites this paper
• Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients

  2023cites this paper
• Population pharmacokinetics of antibacterial agents in the older population: a literature review

  2023cites this paper
• Tutorial on model selection and validation of model input into precision dosing software for model‐informed precision dosing

  2023influential citation
• 24/7 Therapeutic Drug Monitoring of Beta-Lactam Antibiotics with CLAM-2000

  2023cites this paper
• Assessing the performance of QSP models: biology as the driver for validation

  2023cites this paper
• Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance.

  2023cites this paper
• Advances in antibacterial treatment of adults with high-risk febrile neutropenia.

  2023cites this paper
• Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients

  2023cites this paper
• Impact of Vancomycin Loading Doses and Dose Escalation on Glomerular Function and Kidney Injury Biomarkers in a Translational Rat Model

  2023cites this paper
• A Systematic Review on Antimicrobial Pharmacokinetic Differences between Asian and Non-Asian Adult Populations

  2023influential citation
• Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicenter retrospective study in critically ill patients without any form of dialysis.

  2023cites this paper
• Synthetic Model Combination: A new machine‐learning method for pharmacometric model ensembling

  2023cites this paper
• In silico Evaluation of a Vancomycin Dosing Guideline Among Adults with Serious Infections

  2023cites this paper
• The Role of Surface Enhanced Raman Scattering for Therapeutic Drug Monitoring of Antimicrobial Agents

  2022cites this paper
• Hemoperfusion with Seraph 100 Microbind Affinity Blood Filter Unlikely to Require Increased Antibiotic Dosing: A Simulations Study Using a Pharmacokinetic/Pharmacodynamic Approach

  2022cites this paper
• Comparison of Race‐Based and Non–Race‐Based Equations for Kidney Function Estimation in Critically Ill Thai Patients for Vancomycin Dosing

  2022cites this paper
• Augmented Renal Clearance in Severe Infections—An Important Consideration in Vancomycin Dosing: A Narrative Review

  2022influential citation
• Optimized sampling to estimate vancomycin drug exposure: Comparison of pharmacometric and equation‐based approaches in a simulation‐estimation study

  2022cites this paper
• Vancomycin dosing in an obese patient with acute renal failure: A case report and review of literature

  2022cites this paper
• A Machine Learning Approach to Predict Interdose Vancomycin Exposure

  2022cites this paper
• Ensuring target concentrations of antibiotics in critically ill patients through dose adjustment

  2022cites this paper
• Impact of vancomycin loading doses and dose escalation on glomerular function and kidney injury biomarkers in a translational rat model

  2022cites this paper
• Synthetic Model Combination: An Instance-wise Approach to Unsupervised Ensemble Learning

  2022cites this paper
• Are Antibiotics Appropriately Dosed in Critically Ill Patients with Augmented Renal Clearance? A Narrative Review

  2022influential citation
• Critical assessment of the revised guidelines for vancomycin therapeutic drug monitoring.

  2022cites this paper
• Efficacy and Safety of Continuous Infusion of Vancomycin in Critically Ill Adults: A Systematic Review

  2022cites this paper
• Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults

  2022cites this paper
• Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections in Critically Ill Patients: Focus on Novel Infusion Mode

  2022cites this paper
• Review and evaluation of vancomycin dosing guidelines for obese individuals

  2022cites this paper
• Vancomycin AUC values estimated with trough-only data: Accuracy in an adult academic medical center population.

  2022cites this paper
• Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models.

  2022cites this paper
• Impact of vancomycin loading doses and dose escalation on glomerular function and kidney injury biomarkers in a translational rat model

  2022cites this paper
• Bayesian method application: Integrating mathematical modeling into clinical pharmacy through vancomycin therapeutic monitoring

  2022cites this paper
• Antimicrobial safety considerations in critically ill patients: part I: focused on acute kidney injury

  2022cites this paper
• PK / PD and the Drug Delivery Regimen for Infusion in the Critical Care Setting

  2021cites this paper
• Precision Drug Delivery for Vancomycin Efficacy and Safety in Critically Ill Patients

  2021cites this paper
• Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

  2021cites this paper
• Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.

  2021cites this paper
• Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants

  2021cites this paper
• Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance

  2021cites this paper
• Prediction of vancomycin dose on high-dimensional data using machine learning techniques

  2021cites this paper
• Vancomycin Adsorption During in vitro Model of Hemoperfusion with HA380 Cartridge

  2021cites this paper
• Competence Mining of Vancomycin (VAN) in the Management of Infections Due to Bacterial Strains With High VAN Minimum Inhibitory Concentrations (MICs): A Novel Dosing Strategy Based on Pharmacokinetic/Pharmacodynamic Modeling

  2021cites this paper
• A Free Open-Source Bayesian Vancomycin Dosing App for Adults: Design and Evaluation Study

  2021influential citation
• Comparison of area under the curve for vancomycin from one- and two-compartment models using sparse data

  2021cites this paper
• Continuous Infusion Vancomycin in Pediatric Patients: A Critical Review of the Evidence.

  2020cites this paper
• An Update on Population Pharmacokinetic Analyses of Vancomycin, Part I: In Adults

  2020cites this paper
• Prospective validation of a model‐informed precision dosing tool for vancomycin in intensive care patients

  2020influential citation
• Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Socie

  2020cites this paper
• The antibiotic vancomycin induces complexation and aggregation of gastrointestinal and submaxillary mucins

  2020cites this paper
• Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study

  2020cites this paper
• Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice.

  2020cites this paper
• Home intravenous antibiotherapy and the proper use of elastomeric pumps: Systematic review of the literature and proposals for improved use.

  2020cites this paper
• Vancomycin Serum Concentration after 48 h of Administration: A 3-Years Survey in an Intensive Care Unit

  2020cites this paper
• Population pharmacokinetics of vancomycin in patients with external ventricular drain‐associated ventriculitis

  2020cites this paper
• Safety considerations of current drug treatment strategies for nosocomial pneumonia

  2020cites this paper
• Why we should sample sparsely and aim for a higher target: Lessons from model‐based therapeutic drug monitoring of vancomycin in intensive care patients

  2020cites this paper
• What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from a PK simulation modelling.

  2020cites this paper
• Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients.

  2020cites this paper
• Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients

  2020cites this paper
• A Model Averaging/Selection Approach Improves the Predictive Performance of Model‐Informed Precision Dosing: Vancomycin as a Case Study

  2020cites this paper
• Vancomycin Area under the Curve and Pharmacokinetic Parameters during the First 24 Hours of Treatment in Critically Ill Patients using Bayesian Forecasting

  2020cites this paper
• Terms of use of outpatient parenteral antibiotic therapy.

  2020cites this paper
• Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients.

  2019cites this paper
• Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock — rationale and design of a multicenter randomized controlled superiority trial

  2019cites this paper
• CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational study

  2019cites this paper
• Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations

  2019cites this paper
• Chemical pharmacotherapy for hospital-acquired pneumonia in the elderly

  2019cites this paper
• Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients

  2019cites this paper
• Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: population pharmacokinetic modelling and simulations for improved dosing schemes.

  2019cites this paper
• Basic Principles of Antibiotics Dosing in Patients with Sepsis and Acute Kidney Damage Treated with Continuous Venovenous Hemodiafiltration

  2019influential citation
• Pharmacokinetics and Pharmacodynamics of Antibiotics in Transplant Patients

  2019cites this paper
• Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population

  2019cites this paper
• Mathematical Models for Optimisation of Drug Administration in Intensive Care Units

  2019influential citation
• Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.

  2019cites this paper
• Kajian Narrative terhadap Profil Farmakokinetik Antibiotik pada Pasien Kritis: Implikasi terhadap Ketercapaian Target Farmakokinetik-Farmakodinamik

  2019cites this paper
• Therapeutic monitoring of vancomycin: A revised consensus guideline and review

  2019cites this paper
• Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?

  2019cites this paper
• External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit Patients

  2019influential citation
• Attainment of therapeutic vancomycin level within the first 24 h

  2019cites this paper
• Appropriate Antimicrobial Therapy in Critically Ill Patients

  2018cites this paper
• Acute Kidney Injury and Renal Replacement Therapy

  2018cites this paper
• Generic and Optimized Antibacterial Dosing Strategies in the Critically Ill

  2018cites this paper
• Population pharmacokinetics analysis of vancomycin in critically ill patients

  2018cites this paper
• Augmented Renal Clearance

  2018cites this paper